(Other OTC/NBB : OREO)

( )
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield

Message Boards



Health Technology » Biotechnology

Company Profile

Avant Diagnostics, Inc. is a healthcare data generating technology company, which specializes in biomarker assay services in the areas of oncology. It provides personalized medicine data through its TheraLink assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders to over 70 FDA-approved drug treatments. The firm also develops phospho-proteomic technologies that measure the activation status of key signaling pathways, with applications in cancer types including breast, colorectal, non-small cell lung cancer, and pancreatic. The company was founded on October 16, 2008 and is headquartered in Washington, DC.